688029 南微医学
已收盘 02-27 15:00:00
资讯
新帖
简况
南微医学公布国际专利申请：“内窥镜用引流装置和引流方法”
证券之星 · 01-31
南微医学公布国际专利申请：“内窥镜用引流装置和引流方法”
每周股票复盘：南微医学（688029）股东会通过2026年度日常关联交易预计
证券之星 · 01-18
每周股票复盘：南微医学（688029）股东会通过2026年度日常关联交易预计
南微医学（688029）披露2026年度日常关联交易额度预计议案获股东会通过，1月12日股价下跌0.17%
证券之星 · 01-12
南微医学（688029）披露2026年度日常关联交易额度预计议案获股东会通过，1月12日股价下跌0.17%
每周股票复盘：南微医学（688029）拟2026年与康宏医疗开展不超1.224亿关联交易
证券之星 · 01-11
每周股票复盘：南微医学（688029）拟2026年与康宏医疗开展不超1.224亿关联交易
每周股票复盘：南微医学（688029）将召开2026年首次临时股东会
证券之星 · 2025-12-28
每周股票复盘：南微医学（688029）将召开2026年首次临时股东会
南微医学预计2026年向关联方江苏康宏采购商品及劳务总额1.22亿元
中金财经 · 2025-12-27
南微医学预计2026年向关联方江苏康宏采购商品及劳务总额1.22亿元
南微医学选举张博为职工代表董事，完善公司治理结构
中金财经 · 2025-12-27
南微医学选举张博为职工代表董事，完善公司治理结构
南微医学（688029）披露召开2026年第一次临时股东会通知，12月26日股价下跌0.24%
证券之星 · 2025-12-26
南微医学（688029）披露召开2026年第一次临时股东会通知，12月26日股价下跌0.24%
12月17日南微医学涨5.78%，中庚价值先锋股票基金重仓该股
证券之星 · 2025-12-17
12月17日南微医学涨5.78%，中庚价值先锋股票基金重仓该股
南微医学涨5.78%，国金证券一个月前给出“买入”评级
证券之星 · 2025-12-17
南微医学涨5.78%，国金证券一个月前给出“买入”评级
南微医学（688029）披露持股5%以上股东减持股份结果公告，12月08日股价上涨0.34%
证券之星 · 2025-12-08
南微医学（688029）披露持股5%以上股东减持股份结果公告，12月08日股价上涨0.34%
每周股票复盘：南微医学（688029）本周现超7000万大宗交易
证券之星 · 2025-11-16
每周股票复盘：南微医学（688029）本周现超7000万大宗交易
11月14日南微医学现5806.94万元大宗交易
证券之星 · 2025-11-14
11月14日南微医学现5806.94万元大宗交易
南微医学（688029）披露取消监事会并修订公司章程议案获通过，11月12日股价下跌0.31%
证券之星 · 2025-11-12
南微医学（688029）披露取消监事会并修订公司章程议案获通过，11月12日股价下跌0.31%
11月11日南微医学现1292.56万元大宗交易
证券之星 · 2025-11-11
11月11日南微医学现1292.56万元大宗交易
每周股票复盘：南微医学（688029）拟取消监事会改由董事会审计委员会履职
证券之星 · 2025-11-09
每周股票复盘：南微医学（688029）拟取消监事会改由董事会审计委员会履职
南微医学（688029）披露拟取消监事会并修订多项治理制度，11月06日股价上涨0.83%
证券之星 · 2025-11-06
南微医学（688029）披露拟取消监事会并修订多项治理制度，11月06日股价上涨0.83%
南微医学（688029）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 2025-10-29
南微医学（688029）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
南微医学(688029)9月30日股东户数1.25万户，较上期增加1.38%
证券之星 · 2025-10-28
南微医学(688029)9月30日股东户数1.25万户，较上期增加1.38%
南微医学最新公告：前三季度净利润同比增长12.90%
证券之星 · 2025-10-27
南微医学最新公告：前三季度净利润同比增长12.90%
暂无数据
公司概况
公司名称：
南微医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-07-22
主营业务：
南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜诊疗器械、微波/射频消融设备及耗材、一次性内镜。
发行价格：
52.45
{"stockData":{"symbol":"688029","market":"SH","secType":"STK","nameCN":"南微医学","latestPrice":82.53,"timestamp":1772175600000,"preClose":82.67,"halted":0,"volume":1270363,"delay":0,"changeRate":-0.0017,"floatShares":188000000,"shares":188000000,"eps":3.2548,"marketStatus":"已收盘","change":-0.14,"latestTime":"02-27 15:00:00","open":82.02,"high":84.13,"low":82.02,"amount":105000000,"amplitude":0.0255,"askPrice":82.66,"askSize":10,"bidPrice":82.53,"bidSize":8,"shortable":0,"etf":0,"ttmEps":3.2548,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":5,"adr":0,"adjPreClose":82.67,"symbolType":"stock_kcb","openAndCloseTimeList":[[1772155800000,1772163000000],[1772168400000,1772175600000]],"highLimit":90.94,"lowLimit":74.4,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":187847422,"isCdr":false,"pbRate":3.81,"roa":"--","peRate":25.356397,"roe":"12.75%","epsLYR":2.95,"committee":-0.15942,"marketValue":15503000000,"turnoverRate":0.0068,"status":1,"afterMarket":{"amount":0,"volume":0,"close":82.53,"buyVolume":4062,"sellVolume":0,"time":1772177637558,"indexStatus":"已收盘 02-27 15:30:00","preClose":82.67},"floatMarketCap":15503000000},"requestUrl":"/m/hq/s/688029/tweets","defaultTab":"tweets","newsList":[{"id":"2607022753","title":"南微医学公布国际专利申请：“内窥镜用引流装置和引流方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2607022753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607022753?lang=zh_cn&edition=full","pubTime":"2026-01-31 06:45","pubTimestamp":1769813140,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示南微医学（688029）公布了一项国际专利申请，专利名为“内窥镜用引流装置和引流方法”，专利申请号为PCT/CN2025/109868，国际公布日为2026年1月29日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来南微医学已公布的国际专利申请1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了8828.23万元，同比增26.88%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013100005146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2604923771","title":"每周股票复盘：南微医学（688029）股东会通过2026年度日常关联交易预计","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923771?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:22","pubTimestamp":1768677729,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，南微医学报收于87.22元，较上周的87.15元上涨0.08%。本周，南微医学1月14日盘中最高价报89.93元。本周关注点公司公告汇总：股东会审议通过《关于2026年度日常关联交易额度预计的议案》，决议合法有效。公司公告汇总江苏新高的律师事务所对南微医学科技股份有限公司2026年第一次临时股东会的召集、召开程序、出席人员资格、表决方式、表决程序和表决结果进行了见证。出席会议股东132人，代表表决权55.8855%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2602545086","title":"南微医学（688029）披露2026年度日常关联交易额度预计议案获股东会通过，1月12日股价下跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602545086","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602545086?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:20","pubTimestamp":1768227630,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，南微医学报收于87.0元，较前一交易日下跌0.17%，最新总市值为163.43亿元。该股当日开盘87.77元，最高88.58元，最低85.5元，成交额达1.73亿元，换手率为1.06%。近日，南微医学科技股份有限公司召开2026年第一次临时股东会，审议通过《关于2026年度日常关联交易额度预计的议案》。出席会议股东132人，代表表决权55.8855%。议案获普通决议通过，中小投资者已单独计票。江苏新高的律师事务所见证会议并出具法律意见书，认为会议决议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2602533027","title":"每周股票复盘：南微医学（688029）拟2026年与康宏医疗开展不超1.224亿关联交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2602533027","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602533027?lang=zh_cn&edition=full","pubTime":"2026-01-11 02:13","pubTimestamp":1768068788,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，南微医学报收于87.15元，较上周的81.56元上涨6.85%。本周，南微医学1月8日盘中最高价报87.87元。本周关注点公司公告汇总：南微医学拟2026年与康宏医疗开展不超1.224亿元日常关联交易公司公告汇总南微医学科技股份有限公司预计2026年度与关联方江苏康宏医疗科技有限公司发生日常关联交易，主要包括采购弹簧管、注塑件、挤出件等原材料及委托加工钳头总成等劳务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","159891","BK0251"],"gpt_icon":0},{"id":"2594242698","title":"每周股票复盘：南微医学（688029）将召开2026年首次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2594242698","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594242698?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:52","pubTimestamp":1766865130,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，南微医学报收于83.4元，较上周的81.58元上涨2.23%。本周关注点公司公告汇总：南微医学将于2026年1月12日召开第一次临时股东会，审议2026年度日常关联交易额度预计议案。公司公告汇总南微医学科技股份有限公司将于2026年1月12日召开2026年第一次临时股东会，采用现场与网络投票结合方式，网络投票通过上海证券交易所系统进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2594039211","title":"南微医学预计2026年向关联方江苏康宏采购商品及劳务总额1.22亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594039211","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594039211?lang=zh_cn&edition=full","pubTime":"2025-12-27 10:32","pubTimestamp":1766802723,"startTime":"0","endTime":"0","summary":"中访网数据 南微医学科技股份有限公司于2025年12月26日召开第四届董事会第十三次会议，审议通过了《关于2026年度日常关联交易额度预计的议案》。根据议案，公司预计2026年度将与关联方江苏康宏医疗科技有限公司发生日常关联交易，总额度为人民币12,240万元。 本次预计的关联交易主要包括两大类别：一是向江苏康宏采购商品，预计金额为11,750万元；二是向江苏康宏采购劳务，预计金额为490万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251227/31896336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2594215211","title":"南微医学选举张博为职工代表董事，完善公司治理结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2594215211","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594215211?lang=zh_cn&edition=full","pubTime":"2025-12-27 10:10","pubTimestamp":1766801405,"startTime":"0","endTime":"0","summary":"中访网数据 南微医学科技股份有限公司于近日召开职工代表大会，审议通过了关于选举职工代表董事的议案。会议决议，选举张博先生为公司第四届董事会职工代表董事。其任期自本次职工代表大会审议通过之日起，至公司第四届董事会任期届满之日止。根据公告，张博先生现任公司董事、高级副总裁，拥有丰富的医疗器械行业管理及营销经验。公司表示，新任职工代表董事将依法依规行使职权，参与公司重大决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251227/31896321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2594294176","title":"南微医学（688029）披露召开2026年第一次临时股东会通知，12月26日股价下跌0.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594294176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594294176?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:38","pubTimestamp":1766759895,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，南微医学报收于83.4元，较前一交易日下跌0.24%，最新总市值为156.66亿元。该股当日开盘83.96元，最高84.09元，最低82.62元，成交额达8163.3万元，换手率为0.52%。公司近日发布公告称，南微医学科技股份有限公司将于2026年1月12日召开2026年第一次临时股东会，会议采取现场投票与网络投票相结合的方式，网络投票通过上海证券交易所系统进行。股权登记日为2026年1月5日，登记时间为2025年1月9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600036682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2592964078","title":"12月17日南微医学涨5.78%，中庚价值先锋股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592964078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592964078?lang=zh_cn&edition=full","pubTime":"2025-12-17 15:33","pubTimestamp":1765956820,"startTime":"0","endTime":"0","summary":"证券之星消息，12月17日南微医学涨5.78%，收盘报81.85元，换手率1.44%，成交量2.7万手，成交额2.17亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共38家，其中持有数量最多的公募基金为中庚基金的中庚价值先锋股票。中庚价值先锋股票目前规模为32.36亿元，最新净值1.0268，较上一交易日上涨0.32%，近一年上涨3.29%。陈涛在任的基金产品包括:中庚小盘价值股票，管理时间为2024年7月19日至今，期间收益率为31.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700018663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2592962858","title":"南微医学涨5.78%，国金证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2592962858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592962858?lang=zh_cn&edition=full","pubTime":"2025-12-17 15:33","pubTimestamp":1765956810,"startTime":"0","endTime":"0","summary":"今日南微医学涨5.78%，收盘报81.85元。2025年10月28日，国金证券研究员甘坛焕,何冠洲发布了对南微医学的研报《三季度收入稳定增长，毛利率略有承压》，该研报对南微医学给出“买入”评级。研报中预计2025-2027年公司归母净利润分别为6.45、8.20、10.07亿元，同比+17%、+27%、+23%，现价对应PE为25、20、16倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中金公司的冯喜鹏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700018657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"gpt_icon":0},{"id":"2589339341","title":"南微医学（688029）披露持股5%以上股东减持股份结果公告，12月08日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589339341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589339341?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:52","pubTimestamp":1765187548,"startTime":"0","endTime":"0","summary":"公司近日发布《南微医学科技股份有限公司持股5%以上股东减持股份结果公告》。公告显示，本次减持计划实施前，中科招商持有南微医学科技股份有限公司股份41,752,818股，占公司总股本的22.2270%。2025年8月18日，公司披露股东中科招商拟减持不超过3,756,948股，不超过公司总股本的2%。截至2025年12月5日，减持计划期限届满，中科招商通过集中竞价交易方式合计减持62,000股，减持比例0.03%，未通过大宗交易方式减持。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2583223651","title":"每周股票复盘：南微医学（688029）本周现超7000万大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2583223651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583223651?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:56","pubTimestamp":1763236573,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，南微医学报收于83.85元，较上周的81.33元上涨3.1%。本周，南微医学11月12日盘中最高价报87.07元。南微医学当前最新总市值157.51亿元，在医疗器械板块市值排名19/126，在两市A股市值排名1219/5165。本周关注点来自交易信息汇总：11月11日及14日南微医学合计发生超7000万元大宗交易。来自公司公告汇总：南微医学2025年第三次临时股东大会审议通过取消监事会并修订公司章程的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2583715005","title":"11月14日南微医学现5806.94万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2583715005","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583715005?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:35","pubTimestamp":1763112929,"startTime":"0","endTime":"0","summary":"证券之星消息，11月14日南微医学发生大宗交易，交易数据如下：大宗交易成交价格82.18元，相对当日收盘价折价1.99%，成交70.66万股，成交金额5806.94万元，买方营业部为广发证券股份有限公司上海玉兰路证券营业部，卖方营业部为广发证券股份有限公司总部。近三个月该股共发生5笔大宗交易，合计成交1.01万手，折价成交1笔。截至2025年11月14日收盘，南微医学报收于83.85元，下跌1.93%，换手率0.59%，成交量1.11万手，成交额9354.95万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2582370561","title":"南微医学（688029）披露取消监事会并修订公司章程议案获通过，11月12日股价下跌0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582370561","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582370561?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:42","pubTimestamp":1762958538,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，南微医学报收于85.9元，较前一交易日下跌0.31%，最新总市值为161.36亿元。该股当日开盘86.17元，最高87.07元，最低85.21元，成交额达1.66亿元，换手率为1.03%。近日，南微医学科技股份有限公司发布2025年第三次临时股东大会决议公告，公司于2025年11月12日召开股东大会，审议通过了《关于取消监事会并修订<公司章程>的议案》及多项公司治理制度修订、新增和废止议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2582547133","title":"11月11日南微医学现1292.56万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2582547133","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582547133?lang=zh_cn&edition=full","pubTime":"2025-11-11 17:27","pubTimestamp":1762853246,"startTime":"0","endTime":"0","summary":"证券之星消息，11月11日南微医学发生大宗交易，交易数据如下：近三个月该股共发生4笔大宗交易，合计成交3000.0手。该股近期无解禁股上市。截至2025年11月11日收盘，南微医学(688029)报收于86.17元，上涨3.89%，换手率1.69%，成交量3.17万手，成交额2.69亿元。该股近半年内有股东持股变动，合计净减持6.2万股，股东增减持明细如下表：该股最近90天内共有13家机构给出评级，买入评级12家，增持评级1家；过去90天内机构目标均价为102.62。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100028327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2582864660","title":"每周股票复盘：南微医学（688029）拟取消监事会改由董事会审计委员会履职","url":"https://stock-news.laohu8.com/highlight/detail?id=2582864660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582864660?lang=zh_cn&edition=full","pubTime":"2025-11-09 05:00","pubTimestamp":1762635643,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，南微医学报收于81.33元，较上周的82.88元下跌1.87%。本周关注点公司公告汇总：南微医学拟取消监事会，由董事会审计委员会行使监事会职权公司公告汇总：公司将修订《公司章程》及相关治理制度，新增《董事高管薪酬管理制度》公司公告汇总：相关议案已通过董事会及监事会审议，将提交股东大会审议公司公告汇总南微医学科技股份有限公司拟取消监事会，由董事会审计委员会行使监事会职权，并据此修订《公司章程》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2581605703","title":"南微医学（688029）披露拟取消监事会并修订多项治理制度，11月06日股价上涨0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581605703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581605703?lang=zh_cn&edition=full","pubTime":"2025-11-06 17:26","pubTimestamp":1762421165,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，南微医学报收于82.45元，较前一交易日上涨0.83%，最新总市值为154.88亿元。该股当日开盘81.77元，最高82.95元，最低81.3元，成交额达1.29亿元，换手率为0.83%。根据近日发布的《南微医学科技股份有限公司2025年第三次临时股东大会会议资料》，公司拟取消监事会，由董事会审计委员会行使监事会职权，并据此修订《公司章程》。上述议案已分别经公司第四届董事会第十一次会议及第四届监事会第九次会议审议通过，现提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600027130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2579191536","title":"南微医学（688029）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2579191536","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579191536?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:16","pubTimestamp":1761689801,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期南微医学发布2025年三季报。截至本报告期末，公司营业总收入23.81亿元，同比上升18.29%，归母净利润5.09亿元，同比上升12.9%。按单季度数据看，第三季度营业总收入8.15亿元，同比上升20.12%，第三季度归母净利润1.46亿元，同比上升3.74%。本报告期南微医学公司应收账款体量较大，当期应收账款占最新年报归母净利润比达97.88%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900008803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"gpt_icon":0},{"id":"2578936986","title":"南微医学(688029)9月30日股东户数1.25万户，较上期增加1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578936986","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578936986?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:23","pubTimestamp":1761643396,"startTime":"0","endTime":"0","summary":"证券之星消息，近日南微医学披露，截至2025年9月30日公司股东户数为1.25万户，较6月30日增加170.0户，增幅为1.38%。在医疗器械行业个股中，南微医学股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年6月30日至2025年9月30日，南微医学区间涨幅为49.32%，在此期间股东户数增加170.0户，增幅为1.38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2578962848","title":"南微医学最新公告：前三季度净利润同比增长12.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578962848","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578962848?lang=zh_cn&edition=full","pubTime":"2025-10-27 23:00","pubTimestamp":1761577236,"startTime":"0","endTime":"0","summary":"南微医学(688029.SH)公告称，第三季度营收为8.15亿元，同比增长20.12%；净利润为1.46亿元，同比增长3.74%。前三季度营收为23.81亿元，同比增长18.29%；净利润为5.09亿元，同比增长12.90%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700037153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772190355726,"stockEarnings":[{"period":"1week","weight":0.0429},{"period":"1month","weight":0.022},{"period":"3month","weight":0.0446},{"period":"6month","weight":-0.0909},{"period":"1year","weight":0.1932},{"period":"ytd","weight":0.0136}],"compareEarnings":[{"period":"1week","weight":0.0158},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0664},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.2267},{"period":"ytd","weight":0.0448}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南微医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"12515人(较上一季度增加1.38%)","perCapita":"15009股","listingDate":"2019-07-22","address":"江苏省南京市浦口区高新开发区高科三路10号","registeredCapital":"18784万元","survey":" 南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜诊疗器械、微波/射频消融设备及耗材、一次性内镜。","listedPrice":52.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南微医学,688029,南微医学股票,南微医学股票老虎,南微医学股票老虎国际,南微医学行情,南微医学股票行情,南微医学股价,南微医学股市,南微医学股票价格,南微医学股票交易,南微医学股票购买,南微医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}